Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer?

Pathology

Volumn 47, Issue 3, 2015, Pages 257-269

  Halliday, C L ^a,b   Kidd, S E ^c   Sorrell, T C ^b,d   Chen, S C A ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c SA Pathology   (Australia)

^d University of Sydney   (Australia)

Author keywords

DNA sequencing; fungal infections; molecular diagnosis; PCR

Indexed keywords

HUMAN; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; MYCOSES; TRENDS;

HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOLOGICAL TYPING TECHNIQUES; MYCOSES;

EID: 84929512566     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000234     Document Type: Article

References (164)

1. 1. Arvanitis, M., Anagnostou, T., Burgwyn Fuchs, B., Molecular and non molecular diagnostic methods for invasive fungal infections. Clin Micro-biol Rev 27 (2014), 490–526.
2. 2. Gómez, B.L., Molecular diagnosis of endemic and invasive mycoses: advances and challenges. Rev Iberoam Micol 31 (2014), 35–41.
3. 3. Chen, S.C.A., Halliday, C.L., Meyer, W., A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med Mycol 40 (2002), 333–357.
4. 4. White, P.L., Perry, M.D., Barnes, R.A., An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiol Lett 296 (2009), 1–10.
5. 5. Khot, P.D., Fredericks, D.N., PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther 7 (2009), 1201–1221.
6. 6. Hammond, S.P., Bialek, R., Milner, D.A., et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol 49 (2011), 2151–2153.
7. 7. Clinical and Laboaratory Standards Institute (CLSI). Interpretative criteria for identification of bacteria and fungi by DNA sequencing; approved guideline. CLSI document MM18-A, 2008, CLSI, Wayne, PA.
8. 8. Schoch, C.L., Seifart, K.A., Huhndorf, S., et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal barcode marker for Fungi. PNAS 109 (2012), 6241–6246.
9. 9. Balajee, S.A., Borman, A.M., Brandt, M.E., Sequence-based identification of Aspergillus, Fusarium and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here?. J Clin Microbiol 47 (2009), 877–884.
10. 10. Lau, A., Chen, A., Sorrell, T., Development and clinical application of a panfungal assay to detect and identify fungal in tissue specimens. J Clin Microbiol 45 (2007), 380–385.
11. 11. Rickerts, V., Mousset, S., Lambrecht, E., et al. Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 44 (2007), 1078–1083.
12. 12. Landlinger, C., Preuner, S., Basková, L., et al. Diagnosis of invasive fungal infections by real-time panfungal assay in immunocompromised pediatric patients. Leukemia 24 (2010), 2032–2038.
13. 13. Babouee, B., Goldenberger, D., Elzi, L., et al. Prospective study of a panfungal assay followed by sequencing, for detection of fungal in normally sterile specimens in a clinical setting: a complimentary tool in the diagnosis of invasive fungal disease. Clin Microbiol Infect 19 (2013), E354–E357.
14. 14. Lass-Flörl, C., Mutschlechner, W., Aigner, M., Utility of in diagnosis of invasive fungal infections: real-life data from a multicentre study. J Clin Microbiol 51 (2013), 863–868.
15. 15. Sugawara, Y., Nakase, K., Nakumura, A., et al. Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders. Eur J Haematol 90 (2013), 331–339.
16. 16. Jordanides, N.E., Allan, E.K., McLintock, L.A., et al. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients. Bone Marrow Transplant 35 (2005), 389–395.
17. 17. Badiee, P., Kordbacheh, P., Alborzi, A., et al. Study on invasive fungal infections in immunocompromised patients to present a suitable early diagnostic procedure. Int J Infect Dis 13 (2009), 97–102.
18. 18. Babady, N.E., Miranda, E., Gilhuley, K.A., Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi. J Clin Microbiol 49 (2011), 3777–3782.
19. 19. Mancini, N., Clerici, D., Diotti, R., et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 57 (2008), 601–604.
20. 20. von Lilienfeld-Toal, M., Lehmann, L.E., Raadts, A.D., et al. Utility of a commercially available multiplex real-time assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 47 (2009), 2405–2410.
21. 21. Lamoth, F., Jaton, K., Prod'hom, G., et al. Multiplex blood in combination with blood cultures for improvement of the microbiological documentation of infection in febrile neutropenia. J Clin Microbiol 48 (2010), 3510–3516.
22. 22. Clancy, C.J., Nguyen, M.H., Finding the “missing 50%’” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 56 (2013), 1284–1292.
23. 23. Pfeiffer, C.D., Samsa, G.P., Schell, W.A., et al. Quantitation of Candida CFU in initial positive blood cultures. J Clin Microbiol 49 (2011), 2879–2883.
24. 24. Kourkoumpetis, T.K., Fuchs, B.B., Coleman, J.J., et al. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis 54 (2012), 1322–1331.
25. 25. Fortún, J., Meije, Y., Buitrago, M.J., et al. Clinical validation of a multiplex real-time assay for detection of invasive candidiasis in intensive care unit patients. J Antimicrob Chemother 69 (2014), 3134–3141.
26. 26. Avni, T., Leibovici, L., Paul, M., PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 49 (2011), 665–670.
27. 27. Chen, S., Slavin, M., Nguyen, Q., et al. Active surveillance for candidemia, Australia. Emerg Infect Dis 12 (2006), 1508–1516.
28. 28. Alam, F.F., Mustafa, A.S., Khan, Z.U., Comparative evaluation of (1, 3)-ß-D-glucan, mannan and antimannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis, 7, 2007, 103.
29. 29. Ahmad, S., Khan, Z., Mustafa, A.S., et al. Seminested for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 40 (2002), 2483–2489.
30. 30. McMullan, R., Metwally, L., Coyle, P.V., et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 46 (2008), 890–896.
31. 31. Lau, A., Halliday, C., Chen, S.C.A., et al. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 48 (2010), 811–816.
32. 32. Nguyen, M.H., Wissel, M.C., Shields, R.K., et al. Performance of Candida realtime polymerase chain reaction, ß-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 54 (2012), 1240–1248.
33. 33. Metwally, L., Hogg, G., Coyle, P.V., et al. Rapid differentiation between fluconazole-sensitive and –resistant species of Candida directly from positive blood-culture bottles by real-time PCR. J Med Microbiol 56 (2007), 964–970.
34. 34. Lau, A., Sorrell, T.C., Chen, S., et al. Multiplex-tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol 46 (2008), 3021–3027.
35. 35. Metwally, L., Fairley, D.J., Coyle, P.V., et al. Comparison of serum and whole-blood specimens for the detection of Candida in critically ill, nonneu-tropenic patients. J Med Microbiol 57 (2008), 1269–1272.
36. 36. Neely, L.A., Audeh, M., Phung, N.A., et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candiemia in whole blood. Sci Transl Med, 5, 2013, 112ra54.
37. 37. Beyda, N.D., Alam, M.J., Garey, K.W., Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis 77 (2013), 324–326.
38. 38. Halliday, C.L., Hoile, R., Sorrell, T., et al. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br J Haematol 132 (2006), 478–486.
39. 39. White, P.L., Linton, C.J., Perry, M.D., et al. The evolution and evaluation of whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 42 (2006), 479–486.
40. 40. Mengoli, C., Cruciani, M., Barnes, R., et al. Use of for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 9 (2009), 89–96.
41. 41. Arvanitis, M., Ziakas, P., Zacharioudakis, I.M., et al. In Diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol 52 (2014), 3731–3742.
42. 42. De Pauw, B., Walsh, T.J., Donnelly, J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46 (2008), 1813–1821.
43. 43. White, P.L., Bretagne, S., Klingspor, L., et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 48 (2010), 1231–1240.
44. 44. White, P.L., Perry, M.D., Loeffler, J., et al. Critical stages of extracting from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol 48 (2010), 3753–3755.
45. 45. Bernal-Martinez, L., Gago, S., Buitrago, M.J., et al. Analysis of performance of a PCR-based assay to detect of Aspergillus fumigatus in whole blood and serum: a comparative study with clinical samples. J Clin Microbiol 49 (2011), 3596–3599.
46. 46. Springer, J., Morton, C.O., Perry, M., et al. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk haematological patients. J Clin Microbio 51 (2013), 1445–1450.
47. 47. Suarez, F., Lortholary, O., Buland, S., et al. Detection of circulating Aspergillus fumigatus by real-time assay of large volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. J Clin Microbiol 46 (2008), 3772–3777.
48. 48. White, P.L., Mengoli, C., Bretagne, S., et al. Evaluation of Aspergillus protocols for testing serum specimens. J Clin Microbiol 49 (2011), 3842–3848.
49. 49. Sun, W., Wang, K., Gao, W., et al. Evaluation of on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: a bivariate meta-analysis and systematic review. PLoS One, 6, 2011, e28467.
50. 50. Heng, S.C., Chen, S.C.A., Morrissey, C.O., et al. Clinical utility of Aspergillus galactomannan and PCR in broncoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies. Diagn Microbiol Infect Dis 79 (2014), 322–327.
51. 51. White, P.L., Perry, M.D., Moody, A., et al. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J Clin Microbiol 49 (2011), 2169–2174.
52. 52. Torelli, R., Sanguinetti, M., Moody, A., et al. Diagnosis of invasive aspergillosis by a commercial real-time assay for Aspergillus in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 49 (2011), 4273–4278.
53. 53. Danylo, A., Courtemanche, C., Pelletier, R., et al. Performance of MycAssay Aspergillus real-time assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples. Med Mycol 52 (2014), 577–583.
54. 54. Millon, L., Larosa, F., Lepiller, Q., et al. Quantitative polymerase chain reaction detection of circulating in serum for early diagnosis of mycormycosis in immunocompromised patients. Clin Infect Dis 56 (2013), e95–e101.
55. 55. Almyroudis, N.G., Sutton, D.A., Fothergill, A.W., et al. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 51 (2007), 2587–2590.
56. 56. Lengerova, M., Racil, Z., Hrncirova, K., et al. Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immuno-compromised patients with pulmonary infiltrates by use of high-resolution melt analysis. J Clin Microbiol 52 (2014), 2824–2828.
57. 57. Bialek, R., Konrad, F., Kern, J., et al. Based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol 58 (2005), 1180–1184.
58. 58. Cornerly, O.A., Arikan-Akdagli, S., Dannaoui, E., et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20 (2014), 5–25.
59. 59. Kasai, M., Harrington, S.M., Francesconi, A., et al. Detection of a molecular biomarker for zygomycetes by quantitative assays of plasma, bronchoalveolar lavage, and lung tissue ina rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol 46 (2008), 3690–3702.
60. 60. Shendure, J., Ji, H., Next-generation sequencing. Nat Biotechnol 26 (2008), 1135–1145.
61. 61. Kircher, M., Kelson, J., High-throughout sequencing- concepts and limitations. Bioessays 32 (2010), 524–536.
62. 62. Vitale, R.G., de Hoog, G.S., Schwarz, P., et al. Antifungal susceptibility and phylogeny of opportunistic members of the order Mucorales. J Clin Microbiol 50 (2012), 66–75.
63. 63. Walther, G., Pawłowska, J., Alastruey-Izquierdo, A., et al. Barcoding in Mucorales: an inventory of biodiversity. Persoonia 30 (2013), 11–47.
64. 64. Ciardo, D.E., Schär, G., Böttger, E.C., et al. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J Clin Microbiol 44 (2006), 77–84.
65. 65. Huang, C.H., Lee, F.L., Tai, C.J., The beta-tubulin gene as a molecular phylogenetic marker for classification and discrimination of the Saccharomyces sensu stricto complex. Antonie Van Leeuwenhoek 95 (2009), 135–142.
66. 66. Aa, E., Townsend, J.P., Adams, R.I., et al. Population structure and gene evolution in Saccharomyces cerevisiae. FEMS Yeast Res 6 (2006), 702–715.
67. 67. Putignani, L., Paglia, M.G., Bordi, E., et al. Identification of clinically relevant yeast species by sequence analysis of the D2 variable region of the 25-28S rRNA gene. Mycoses 51 (2008), 209–227.
68. 68. Alper, I., Frenette, M., Labrie, S., Ribosomal polymorphisms in the yeast Geotrichum candidum. Fungal Biol 115 (2011), 1259–1269.
69. 69. Katsu, M., Kidd Ando, S.A., et al. The Internal Transcribed Spacers and 5. 8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans complex. FEMS Yeast Res 4 (2004), 377–388.
70. 70. Arabatzis, M., Abel, P., Kanellopoulou, M., et al. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece. Clin Microbiol Infect 20 (2014), 777–783.
71. 71. Balajee, S.A., Houbraken, J., Verweij, P.E., et al. Aspergillus species identification in the clinical setting. Stud Mycol 59 (2007), 39–46.
72. 72. O'Donnell, K., Sutton, D.A., Rinaldi, M.G., et al. Internet-accessible sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 48 (2010), 3708–3718.
73. 73. Barker, A.P., Horan, J.L., Slechta, E.S., et al. Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory. Med Mycol 52 (2014), 537–545.
74. 74. Wang, L., Yokoyama, K., Miyaji, M., Nishimura, K., Mitochondrial cytochrome b gene analysis of Aspergillus fumigatus and related species. J Clin Microbiol 38 (2000), 1352–1358.
75. 75. LoBuglio, K.F., Taylor, J.W., Phylogeny and identification of the human pathogenic fungus Penicillium marneffei. J Clin Microbiol 33 (1995), 85–89.
76. 76. Houbraken, J., Samson, R.A., Phylogeny of Penicillium and the segregation of Trichocomaceae into three families. Stud Mycol 70 (2011), 1–51.
77. 77. Peterson, S.W., Multilocus sequence analysis of Penicillium and Eupenicillium species. Rev Iberoam Micol 23 (2006), 134–138.
78. 78. Serra, R., Peterson, S., CTCOR, Venâncio A. Multilocus sequence identification of Penicillium species in cork bark during plank preparation for the manufacture of stoppers. Res Microbiol 159 (2008), 178–186.
79. 79. Peterson, S.W., Aspergillus and Penicillium identification using sequences: barcode or MLST?. Appl Microbiol Biotechnol 95 (2012), 339–344.
80. 80. Chen, S.C.A., Ellis, D., Sorrell, T.C., Meyer, W., Molecular Detection of Human Pathogens, 1st, 2011, CRC Press, New York Chapter 44, Trichophyton.
81. 81. Gräser, Y., Scott, J., Summerbell, R., The new species concept in dermatophytes - a polyphasic approach. Mycopathologia 166 (2008), 239–256.
82. 82. Rezaei-Matehkolaei, A., Mirhendi, H., Makimura, K., et al. Nucleotide sequence analysis of beta tubulin gene in a wide range of dermatophytes. Med Mycol 52 (2014), 674–688.
83. 83. Lawrence, D.P., Gannibal, P.B., Peever, T.L., Pryor, B.M., The sections of Alternaria: formalising species-group concepts. Mycologia 105 (2013), 530–546.
84. 84. de Hoog, G.S., Horré, R., Molecular taxonomy of the Alternaria and Ulocladium species from humans and their identification in the routine laboratory. Mycoses 45 (2002), 259–276.
85. 85. Abliz, P., Fukushima, K., Takizawa, K., Nishimura, K., Identification of pathogenic dematiaceous fungi and related taxa based on large subunit ribosomal D1/D2 domain sequence analysis. FEMS Immunol Med Microbiol 40 (2004), 41–49.
86. 86. Aroca, A., Raposo, R., Lunello, P., A biomarker for the identification of four Phaeoacremonium species using the beta-tubulin gene as the target sequence. Appl Microbiol Biotechnol 80 (2008), 1131–1140.
87. 87. Lackner, M., de Hoog, G.S., Parascedosporium and its relatives: phylogeny and ecological trends. IMA Fungus 2 (2011), 39–48.
88. 88. Schwarz, P., Bretagne, S., Gantier, J.C., et al. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol 44 (2006), 340–349.
89. 89. Lechevalier, P., Garcia-Hermoso, D., Carol, A., et al. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol 46 (2008), 3169–3172.
90. 90. Chowdhary, A., Kathuria, S., Singh, P.K., et al. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of Mucormycetes in Delhi. India Mycoses 57:Suppl 3 (2014), 97–107.
91. 91. Nyilasi, I., Papp, T., Csernetics, A., et al. High-affinityiron permease (FTR1) gene sequence-based molecular identification of clinicallyimportant Zygomycetes. Clin Microbiol Infect 14 (2008), 393–397.
92. 92. Tintelnot, K., De Hoog, G.S., Antweiler, E., et al. Taxonomic and diagnostic markers for identification of Coccidioides immitis and Coccidioides posadasii. Med Mycol 45 (2007), 385–393.
93. 93. Millar, B.C., Jiru, X., Walker, M.J., et al. False identification of Coccidioides immitis: do molecular methods always get it right?. J Clin Microbiol 41 (2003), 5778–5780.
94. 94. Bialek, R., Kern, J., Herrmann, T., et al. Assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-rich antigen. J Clin Microbiol 42 (2004), 778–783.
95. 95. Komori, T., Sano, A., Yarita, K., et al. Phylogenetic analysis of Histoplasma capsulatum based on partial sequence of the D1/D2 region of the 28S rRNA gene. Nihon Ishinkin Gakkai Zasshi 46 (2005), 291–295.
96. 96. Zhou, X., Rodrigues, A.M., Feng, P., Hoog, G.S., Global ITS diversity in the Sporothrix schenckii complex. Fungal Divers 66 (2014), 153–165.
97. 97. Woo, P.C., Leung, S.Y., To, K.K., et al. Internal transcribed spacer region sequence heterogeneity in Rhizopus microsporus: implications for molecular diagnosis in clinical microbiology laboratories. J Clin Microbiol 48 (2010), 208–214.
98. 98. O'Donnell, K., Cigelnik, E., Nirenberg, H., Molecular systematics and phylogeography of the Gibberella fujikuroi species complex. Mycologia 90 (1998), 465–493.
99. 99. Gilgado, F., Cano, J., Gené, J., Guarro, J., Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 43 (2005), 4930–4942.
100. 100. Borman, A.M., Linton, C.J., Oliver, D., et al. Rapid molecular identification of pathogenic yeasts by pyrosequencing analysis of 35 nucleotides of internal transcribed spacer 2. J Clin Microbiol 48 (2010), 3648–3653.
101. 101. Heinrichs, G., de Hoog, G.S., Haase, G., Barcode identifiers as a practical tool for reliable species assignment of medically important black yeast species. J Clin Microbiol 50 (2012), 3023–3030.
102. 102. Nilsson, R.H., Ryberg, M., Kristiansson, E., et al. Taxonomic reliability of sequences in public sequence databases: A fungal perspective. PLoS One, 1, 2006, e59.
103. 103. Bridge, P.D., Roberts, P.J., Spooner, B.M., Panchal, G., On the unreliability of published sequences. New Phytol 160 (2003), 43–48.
104. 104. White, T.J., Bruns, T., Lee, S., Taylor, J., PCR Protocols: A Guide to Methods and Applications, 1st, 1990, Academic Press, San Diego Chapter 38, Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics.
105. 105. Vilgalys, R., Hester, M., Rapid genetic identification and mapping of enzymatically amplified ribosomal from several Cryptococcus species. J Bacteriol 172 (1990), 4238–4246.
106. 106. Gerrits van den Ende, A.G., de Hoog, G.S., Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud Mycol 43 (1999), 151–162.
107. 107. Gardes, M., Bruns, T.D., ITS primers with enhanced specificity for basidiomycetes-application to the identification of mycorrhizae and rusts. Mol Ecol 2 (1993), 113–118.
108. 108. Martin, K.J., Rygiewicz, P.T., Fungal-specific primers developed for analysis of the ITS region of environmental extracts. BMC Microbiol, 5, 2005, 28.
109. 109. Hanner, R. Data Standards for BARCODE Records in INSDC (BRIs). BARCODE Data Standards v.2.4. 28 February 2012. http://www.barcodeoflife.org/sites/default/files/DWG%20standards%20revision%202.4%20-%2029%20Feb%2012.pdf.
110. 110. Ciardo, D.E., Schär, G., Altwegg, M., et al. Identification of moulds in the diagnostic laboratory—an algorithm implementing molecular and phenotypic methods. Diagn Microbiol Infect Dis 59 (2007), 49–60.
111. 111. Meyer, W., Maszewska, K., Sorrell, T.C., PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol 39 (2001), 185–193.
112. 112. Cadez, N., Raspor, P., de Cock, A.W., et al. Molecular identification and genetic diversity within species of the genera Hanseniaspora and Kloeckera. FEMS Yeast Res 1 (2002), 279–289.
113. 113. Sakai, K., Trabasso, P., Moretti, M.L., et al. Identification of fungal pathogens by visible microarray system in combination with isothermal gene amplification. Mycopathologia 178 (2014), 11–26.
114. 114. Lau, A., Sorrell, T.C., Lee, O., et al. Colony multiplex-tandem for rapid, accurate identification of fungal cultures. J Clin Microbiol 46 (2008), 4058–4060.
115. 115. Denning, D.W., Perlin, D.S., Azole resistance in Aspergillus: a growing public health menace. Future Microbiol 6 (2011), 1229–1232.
116. 116. Vermeulen, E., Lagrou, K., Verweij, P.E., Azole resistance in Aspergillus fumigatus: a growing public health concern. Curr Opin Infect Dis 26 (2013), 493–500.
117. 117. Perlin, D.S., Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management. Drugs 74 (2014), 1573–1585.
118. 118. Pfaller, M.A., Messer, S.A., Woosley, L.N., et al. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cut-off values for characterization of geographic and temporal trends of antifungal resistance. J Clin Microbiol 5 (2013), 2571–2578.
119. 119. Castanheira, M., Messer, S.A., Jones, R.N., et al. Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections. Int J Antimicrob Agents 44 (2014), 320–326.
120. 120. Park, S., Perlin, D.S., Establishing surrogate markers for fluconazole resistance in Candida albicans. Microb Drug Resist 11 (2005), 232–238.
121. 121. Sanglard, D., Bille, J., Candida and Candidiasis, 1st, 2002, ASM Press, Washington DC Chapter 25, Current understanding of the mode of action and of resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections.
122. 122. Xiang, M.J., Liu, J.Y., Ni, P.H., et al. ERG11 mutations associated with azole resistance in clinical isolates of Candida albicans. FEMS Yeast Res 13 (2013), 386–393.
123. 123. Wang, H., Kong, F., Sorrell, T.C., et al. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and sequencing. BMC Microbiol, 9, 2009, 167.
124. 124. Frade, J.P., Warnock, D.W., Arthington-Skaggs, B.A., Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler and fluorescent probe hybridization. J Clin Microbiol 42 (2004), 2085–2093.
125. 125. Alexander, B.D., Johnson, M.D., Pfeiffer, C.D., et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56 (2013), 1724–1732.
126. 126. Lackner, M., Tscherner, M., Schaller, M., et al. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment. Antimicrob Agents Chemother 58 (2014), 3626–3635.
127. 127. Jensen, R.H., Justesen, U.S., Rewes, A., et al. Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei. Antimicrob Agents Chemother 58 (2014), 3550–3552.
128. 128. Fekkar, A., Dannaoui, E., Meyer, I., et al. Emergence of echinocandinresistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy? Eur J Clin Microbiol Infect Dis 33 (2014), 1489–1496.
129. 129. Dudiuk, C., Gamarra, S., Leonardeli, F., et al. Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance. J Clin Microbiol 52 (2014), 2609–2614.
130. 130. Park, S., Kelly, R., Kahn, J.N., et al. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother 49 (2005), 3264–3273.
131. 131. Garcia-Effron, G., Kontoyiannis, D.P., Lewis, R.E., Perlin, D.S., Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob Agents Chemother 52 (2008), 4181–4183.
132. 132. Staab, J.F., Neofytos, D., Rhee, P., et al. Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr. Antimicrob Agents Chemother 58 (2014), 5421–5427.
133. 133. Shields, R.K., Nguyen, M.H., Press, E.G., et al. The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother 56 (2012), 4862–4869.
134. 134. Pfaller, M.A., Diekema, D.J., Boyken, L., et al. Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis. Antimicrob Agents Chemother 49 (2005), 4795–4797.
135. 135. Pham, C.D., Bolden, C.B., Kuykendall, R.J., Lockhart, S.R., Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to echinocandins in Candida glabrata. J Clin Microbiol 52 (2014), 790–795.
136. 136. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. CLSI document M27-S4, 2012, CLSI, Wayne. PA.
137. 137. Cuenca-Estrella, M., Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside. Clin Microbiol Infect 20:Suppl 6 (2014), 54–59.
138. 138. Howard, S.J., Cerar, D., Anderson, M.J., et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15 (2009), 1068–1076.
139. 139. Escribano, P., Peláez, T., Muñoz, P., et al. Is azole resistance in Aspergillus fumigatus a problem in Spain?. Antimicrob Agents Chemother 57 (2013), 2815–2820.
140. 140. Vermeulen, E., Maertens, J., Schoemans, H., Lagrou, K., Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill, 17, 2012, 20326.
141. 141. Van Der Linden, J.W., Warris, A., Verweij, P.E., Aspergillus species intrinsically resistant to antifungal agents. Med Mycol 49:Suppl 1 (2011), S82–S90.
142. 142. Ahmad, S., Khan, Z., Hagen, F., Meis, J.F., Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait. Environ Res 133 (2014), 20–26.
143. 143. Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 51 (2007), 1897–1904.
144. 144. van der Linden, J.W., Snelders, E., Arends, J.P., et al. Rapid diagnosis of azoleresistant aspergillosis by direct using tissue specimens. J Clin Microbiol 48 (2010), 1478–1480.
145. 145. Denning, D.W., Park, S., Lass-Florl, C., et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 52 (2011), 1123–1129.
146. 146. Spiess, B., Seifarth, W., Merker, N., et al. Development of novel assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients. Antimicrob Agents Chemother 56 (2012), 3905–3910.
147. 147. Vermeulen, E., Maertens, J., Schoemans, H., Lagrou, K., Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill, 17, 2012, 20326.
148. 148. Lescar, J., Meyer, I., Akshita, K., et al. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole. J Antimicrob Chemother 69 (2014), 3244–3247.
149. 149. Ahmad, S., Khan, Z., Hagen, F., Meis, J.F., Simple, low-cost molecular assays for TR34/L98H mutations in the cyp51A gene for rapid detection of triazole-resistant Aspergillus fumigatus isolates. J Clin Microbiol 52 (2014), 2223–2227.
150. 150. Spiess, B., Postina, P., Reinwald, M., et al. Incidence of cyp51A key mutations in Aspergillus fumigatus - a study on primary clinical samples of immunocompromised patients in the period of 1995-2013. PLoS One, 9, 2014, e103113.
151. 151. Gabriel, S., Ziaugra, L., Tabbaa, D., SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet, 12, 2009 Chapter 2: Unit 2.
152. 152. Kok, J., Chen, SC-A, Dwyer, D.E., Iredell, J.R., Current status of matrix-assisted laser desorption ionisation-time of flight mass spectrometry in the clinical microbiology laboratory. Pathology 45 (2013), 4–17.
153. 153. Borman, A.M., Johnson, E.M., Genomics and proteomics as compared to conventional phenotypic approaches for the identification of the agents of invasive fungal infection. Curr Fungal Infect Rep 7 (2013), 235–243.
154. 154. Clark, A.E., Kaleta, E.J., Arora, A., Wolk, D.M., Matrix-assisted laser desorption ionisation-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev 26 (2013), 547–603.
155. 155. Firacative, C., Trilles, L., Meyer, W., MALDI-TOF enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex. PLoS One, 7, 2012, e37566.
156. 156. Lau, A.F., Drake, S.K., Calhoun, L.B., et al. Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionizationtime of flight mass spectrometry. J Clin Microbiol 51 (2013), 828–834.
157. 157. Hettick, J.M., Green, B.J., Buskirk, A.D., et al. Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry fingerprinting. Anal Biochem 380 (2008), 276–281.
158. 158. De Carolis, E., Vella, A., Florio, A.R., et al. Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species. J Clin Microbiol 50 (2012), 2479–2483.
159. 159. Vella, A., De CArolis, E., Vaccaro, L., et al. Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis. J Clin Microbiol 51 (2013), 2964–2969.
160. 160. Gu, Z., Hall, T.A., Frinder, M., et al. Evaluation of repetitive sequence and PCR-mass spectrometry for the identification of clinically relevant Candida species. Med Mycol 50 (2012), 259–265.
161. 161. Massire, C., Buelow, D.R., Zhang, S.X., et al. Followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens. J Clin Microbiol 51 (2013), 959–966.
162. 162. Shin, J.H., Ranken, R., Sefers, S.E., et al. Detection, identification and distribution of fungi in bronchoalveolar lavage specimens by use of multilocus coupled with electrospray ionization/mass spectrometry. J Clin Microbiol 51 (2013), 136–141.
163. 163. Faulds, K., Smith, W.E., Graham, D., DNA detection by surface enhanced resonance Raman scattering. Analyst 130 (2005), 1125–1131.
164. 164. White, P.L., Hibbitts, S.J., Perry, M.D., et al. Evaluation of a commercially developed semiautomated PCR-SERS assay for the diagnosis of invasive fungal disease. J Clin Microbiol 52 (2014), 3536–3543.